Skip to main content

Want a detailed portfolio tracker?

Illumina (ILMN) Market Cap (2000 - 2026)

Illumina (ILMN) market cap from Jul 28, 2000 to Jun 2, 2026. The current Illumina (ILMN) market cap is $24B. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Market Cap

Illumina (ILMN) Market Cap CAGR table

PeriodCAGR
1 Year TTM-1.24%
3 Years TTM-18.00%
5 Years TTM-20.65%
10 Years TTM-3.69%
All Time TTM+10.38%

Annual Market Cap change of Illumina (ILMN)

YearMarket CapChange
2026$24B+23.93%
2025$20B-5.55%
2024$21B-3.42%
2023$21B-30.70%
2022$31B-46.60%
2021$58B+4.13%
2020$56B+10.77%
2019$50B+10.61%
2018$45B+38.21%
2017$33B+69.48%
2016$19B-30.65%
2015$28B+7.09%
2014$26B+87.76%
2013$14B+103.04%
2012$6.83B+83.65%
2011$3.72B-52.88%
2010$7.90B+120.29%
2009$3.59B+17.77%
2008$3.04B-29.04%
2007$4.29B+50.75%
2006$2.85B+178.79%
2005$1.02B+48.73%
2004$686M+34.47%
2003$510M+109.20%
2002$244M-71.34%
2001$851M-26.78%
2000$1.16BN/A

Comparison Illumina (ILMN) market cap with competitors

Illumina (ILMN) market cap is $24.19B.

TickerNameMarket CapUpside
TMOThermo Fisher Scientific Inc$169.71B+601.49%
DHRDanaher Corp$122.58B+406.67%
IDXXIdexx Laboratories Inc$43.66B+80.47%
WATWaters Corp$33.59B+38.85%
AAgilent Technologies Inc$32.76B+35.43%
NTRANatera Inc$28.99B+19.83%
IQVIQVIA Holdings Inc$27.65B+14.28%
MTDMettler-Toledo International Inc$23.36B-3.44%
DGXQuest Diagnostics Inc$21.35B-11.74%
LHLaboratory Corp Of America Holdings$21.25B-12.15%
EXASExact Sciences Corp$20.02B-17.26%
GHGuardant Health Inc$16.77B-30.68%
MEDPMedpace Holdings Inc$12.22B-49.47%
RVTYRevvity Inc$10.80B-55.34%
ICLRIcon Plc$9.07B-62.51%
CRLCharles River Laboratories International Inc$7.92B-67.25%
QGENQiagen NV$7.46B-69.18%
SHCSotera Health Company$4.43B-81.70%
RDNTRadnet Inc$4.23B-82.52%
BLLNBilliontoone Inc - Class A$4.18B-82.72%
TWSTTwist Bioscience Corp$3.99B-83.51%
VCYTVeracyte Inc$3.55B-85.33%
OLKOlink Holding AB (publ)$3.24B-86.60%
GRALGRAIL Inc$2.94B-87.86%
ADPTAdaptive Biotechnologies Corp$2.21B-90.86%
WGSGeneDx Holdings Corp - Class A$1.43B-94.09%
CDNACaredx Inc$1.14B-95.30%
PSNLPersonalis Inc$993.52M-95.89%
OPKOpko Health Inc$986.54M-95.92%
CSTLCastle Biosciences Inc$644.09M-97.34%
FLGTFulgent Genetics Inc$516.43M-97.87%
MYGNMyriad Genetics Inc$370.99M-98.47%
PREPrenetics Global Ltd - Class A$276.75M-98.86%
NEONeogenomics Inc$251.93M-98.96%
BDSXBiodesix Inc$149.69M-99.38%
FONRFonar Corp$130.50M-99.46%
XGNExagen Inc$120.68M-99.50%
BNRBurning Rock Biotech Ltd$64.43M-99.73%
PRPOPrecipio Inc$42.01M-99.83%
MDXHMDxHealth SA$37.52M-99.84%
MYNZMainz Biomed N.V.$28.66M-99.88%
MBAICheckCap Ltd$11.93M-99.95%
XWELXWELL Inc$10.94M-99.95%
CHEKCheck-Cap Ltd$9.42M-99.96%
NOTVInotiv Inc$9.32M-99.96%
BIAFBioAffinity Technologies Inc$7.42M-99.97%
NDRAENDRA Life Sciences Inc$6.65M-99.97%
ADVBAdvanced Biomed Inc$5.36M-99.98%
APDNApplied Dna Sciences Inc$3.21M-99.99%
FRESFresh2 Group Limited$2.97M-99.99%
ISPCiSpecimen Inc$1.23M-99.99%
PRPHProPhase Labs Inc$415412.05-100.00%